Anti-angiogenic activity of ShengMaBieJia decoction in vitro and in acute myeloid leukaemia tumour-bearing mouse models

• Autori principali: Mengya Wang (Autore), Bangyun Ma (Autore), Xingbin Dai (Autore), Hong Zhang (Autore), Huibo Dai (Autore), Jingyu Wang (Autore), Li Liu (Autore), Xuemei Sun (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Context ShengMaBieJia decoction (SMBJD) is used to treat solid and hematological tumours; however, its anti-angiogenesis activity remains unclear. Objective This study verified the anti-angiogenic effects of SMBJD in vitro and in tumour-bearing acute myeloid leukaemia (AML) mouse models. Materials a...